• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on - Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis.

作者信息

Chellapandian Hethesh, Jeyachandran Sivakamavalli

机构信息

Lab in Biotechnology and Biosignal Transduction, Department of Orthodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai-77, Tamil Nadu, India.

出版信息

Neurosurg Rev. 2024 Oct 1;47(1):708. doi: 10.1007/s10143-024-02934-8.

DOI:10.1007/s10143-024-02934-8
PMID:39349713
Abstract
摘要

相似文献

1
Comment on - Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis.评论——替莫唑胺和放疗联合贝伐单抗治疗对新诊断的胶质母细胞瘤是否具有临床实用性？一项系统评价和荟萃分析。
Neurosurg Rev. 2024 Oct 1;47(1):708. doi: 10.1007/s10143-024-02934-8.
2
Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis.贝伐珠单抗联合替莫唑胺和放疗治疗新诊断的胶质母细胞瘤是否具有临床获益？一项系统评价和荟萃分析。
Neurosurg Rev. 2024 Aug 20;47(1):445. doi: 10.1007/s10143-024-02667-8.
3
A Systematic Review and Meta-Analysis on the Effectiveness of Radiotherapy and Temozolomide Treatment With or Without Bevacizumab in Patients With Glioblastoma Multiforme.放疗联合替莫唑胺与贝伐珠单抗或不联合贝伐珠单抗治疗胶质母细胞瘤的系统评价和荟萃分析。
Neurol India. 2024 Jul 1;72(4):700-707. doi: 10.4103/neurol-india.Neurol-India-D-23-00346. Epub 2024 Aug 31.
4
Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma.术前新辅助使用贝伐单抗和替莫唑胺治疗新诊断的可切除性胶质母细胞瘤。
J Neurooncol. 2024 Jun;168(2):375-376. doi: 10.1007/s11060-024-04666-7. Epub 2024 Apr 15.
5
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.前体神经胶质母细胞瘤患者在一线放疗和替莫唑胺基础上加用贝伐单抗可能获得总生存获益：AVAglio试验的回顾性分析
J Clin Oncol. 2015 Sep 1;33(25):2735-44. doi: 10.1200/JCO.2015.61.5005. Epub 2015 Jun 29.
6
First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide.贝伐珠单抗联合替莫唑胺一线治疗胶质母细胞瘤可改善患者生存。
J Neurooncol. 2020 Feb;146(3):451-458. doi: 10.1007/s11060-019-03339-0. Epub 2020 Feb 4.
7
A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).一项随机 III 期研究，评估短程放疗联合替莫唑胺治疗新诊断的老年胶质母细胞瘤患者的疗效：日本癌症研究集团研究 JCOG1910（老年Gli o-PIII）。
BMC Cancer. 2021 Oct 15;21(1):1105. doi: 10.1186/s12885-021-08834-0.
8
Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma.放疗或替莫唑胺化疗增强抗 CD47 治疗脑胶质母细胞瘤。
Innate Immun. 2020 Feb;26(2):130-137. doi: 10.1177/1753425919876690. Epub 2019 Sep 23.
9
The efficacy and safety of radiotherapy with adjuvant temozolomide for glioblastoma: A meta-analysis of randomized controlled studies.放疗联合替莫唑胺辅助治疗胶质母细胞瘤的疗效和安全性：一项随机对照研究的荟萃分析。
Clin Neurol Neurosurg. 2020 Sep;196:105890. doi: 10.1016/j.clineuro.2020.105890. Epub 2020 May 26.
10
Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study.新诊断胶质母细胞瘤患者的治疗模式、预后因素和放疗-替莫唑胺治疗与生存的相关性：一项法国全国基于人群的研究。
J Neurooncol. 2019 Mar;142(1):91-101. doi: 10.1007/s11060-018-03065-z. Epub 2018 Dec 6.

本文引用的文献

1
Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis.贝伐珠单抗联合替莫唑胺和放疗治疗新诊断的胶质母细胞瘤是否具有临床获益？一项系统评价和荟萃分析。
Neurosurg Rev. 2024 Aug 20;47(1):445. doi: 10.1007/s10143-024-02667-8.